Transgenic expression of myostatin propeptide prevents diet-induced obesity and insulin resistance

Baoping Zhao1, Robert J Wall, Jinzeng Yang

  • 1Department of Human Nutrition, Food and Animal Sciences, University of Hawaii, Honolulu, HI 96822, USA.

Insights

Inhibiting myostatin in mice promotes skeletal muscle growth and enhances fat utilization. This genetic modification prevents diet-induced obesity and insulin resistance, highlighting muscle

Area of Science:

  • Molecular Biology
  • Metabolic Diseases
  • Genetics

Background:

  • Obesity and insulin resistance pose significant global health challenges.
  • Myostatin is a key negative regulator of skeletal muscle growth and development.
  • Understanding skeletal muscle's role in metabolic health is crucial for obesity prevention.

Purpose of the Study:

  • To investigate the impact of inhibiting myostatin on obesity and insulin resistance.
  • To explore the potential of skeletal muscle growth as a strategy for metabolic disease prevention.
  • To analyze the effects of myostatin propeptide expression on metabolic parameters in mice.

Main Methods:

  • Generation of transgenic mice with muscle-specific expression of the myostatin propeptide cDNA.
  • Assessment of muscle mass, body composition, and metabolic parameters (glucose tolerance, insulin sensitivity) after high-fat diet feeding.
  • Measurement of insulin signaling pathway activation (Akt phosphorylation) and adipokine levels.

Main Results:

  • Transgenic mice exhibited significantly increased muscle mass (45-115% heavier) compared to wild-type controls.
  • Transgenic mice maintained normal blood glucose, insulin sensitivity, and fat mass on a high-fat diet.
  • Wild-type mice on a high-fat diet developed increased fat mass (170-214%) and insulin resistance, unlike transgenic mice.

Conclusions:

  • Disrupting myostatin function via its propeptide promotes dietary fat utilization for muscle growth.
  • Increased adiponectin secretion in transgenic mice may enhance energy partitioning towards skeletal muscles.
  • Targeting myostatin offers a potential therapeutic strategy for preventing obesity and insulin resistance through muscle-adipose tissue crosstalk.